Form 4: Procter & Gamble Executive Matthew W. Janzaruk Reports Stock Option Grant and Dividend Equivalents
SEC Form 4 Filing
Matthew W. Janzaruk, SVP Chief Accounting Officer of Procter & Gamble, reports the acquisition of stock options and dividend equivalents in the form of Restricted Stock Units (RSUs).
Summary
- On October 1, 2024, Matthew W. Janzaruk, SVP Chief Accounting Officer of Procter & Gamble, reported a transaction involving Procter & Gamble's common stock.
- Janzaruk acquired 720.4501 shares of common stock through dividend equivalents in the form of Restricted Stock Units (RSUs).
- He also acquired 12,087 stock options with an exercise price of $173.04, exercisable from October 1, 2027, and expiring on September 29, 2034.
- Following these transactions, Janzaruk directly owns 12,087 derivative securities and 720.4501 shares of common stock, and indirectly owns 7,086.563 shares through a retirement plan trustee.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It reflects routine transactions by a company executive.
Positives
- The acquisition of stock options and RSUs by a top executive signals confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in Janzaruk's holdings of Procter & Gamble stock and derivative securities.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The terms of the stock options, such as the exercise price and expiration date, are typical for executive compensation plans.
- Companies like Unilever, Nestle, and Johnson & Johnson also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the holdings of a key executive.
- The acquisition of stock options aligns the executive's interests with those of shareholders, potentially incentivizing value creation.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of earliest transaction: Acquisition of stock options and dividend equivalents. |
| 10/01/2027 | Stock options become exercisable. |
| 09/29/2034 | Expiration date of the stock options. |
| 10/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.